Vivo Bio Tech has informed that the Board of Directors of the Company at its meeting held on December 16, 2016.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Every Wear Import And Export has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed about results & closure of trading window.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed about quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed about outcome of board meeting held on January 11, 2016.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed that the Trading Window of the Company shall remain closed from January 07, 2016 to January 13, 2016 in accordance with the code of Internal Procedures and Conduct for Prevention of Insider Trading in dealing with securities of Vivo Bio Tech Limited, by the reason of the scheduled Board Meeting on January 11, 2016.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed about adoption of policies.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed that a meeting of Board of Directors is scheduled to be held on August 12, 2015, to consider the Unaudited Financial Results for quarter ended June 30, 2015. In this connection, as per Company’s Code of Conduct for Prevention of Insider Trading, the trading window will be closed for dealing in Securities for all Directors / Officers / Designated employees of the Company from August 06, 2015 to August 14, 2015. The Communication has been circulated to all Directors/ Officers/ Designated employees.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed that the Board of Directors of the Company at its meeting held on March 20, 2015, has considered and approved appointment of Sharmistha Manna as Woman Director of the Company.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014.The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014.The above information is a part of company’s filings submitted to BSE.